NUWELLIS INC
NUWENASDAQTrading Snapshot
- Day Range
- $4.42 – $5.66
- 52-Week Range
- $2.52 – $1,556.07
- Volume (shares)
- 2,075,140
- Avg Volume (shares)
- —
- Shares Outstanding
- 92,200
- Next Earnings
- 2026-11-10
Fundamentals Snapshot
- Annual Revenue
- $8M
- Last Q Revenue
- $2M
- P/E Ratio
- -0.0
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-552.19
- Dividend Yield
- 0.00%
- Dilution (1yr)
- −52.1%
NUWELLIS INC
NUWE
StockOtter · stockotter.spaceAbout NUWELLIS INC
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
ⓘLatest News & Updates
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology
ULTRA-Peds Registry evaluated 91 pediatric patients across seven leading children's hospitals, providing important clinical evidence which the Company intends to use to support its proposed label expansion of Aquadex's i
Nuwellis, Inc. (NASDAQ:NUWE) Shares Shorted: Short Interest Up 339.6% in September
Nuwellis, Inc. (NASDAQ: NUWE - Get Free Report) saw a significant increase in short interest in September. As of September 30th, there was short interest totaling 167,440 shares, an increase of 339.6% from the September
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
MINNEAPOLIS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will convene
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced its participation in
Nuwellis, Inc. (NASDAQ:NUWE) Sees Significant Decline in Short Interest
Nuwellis, Inc. (NASDAQ: NUWE - Get Free Report) was the recipient of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 38,092 shares, a decrea
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
Year-to-date console sales exceed full-year console sales in seven of the past 10 years, putting Nuwellis on pace for one of its strongest years in console placements Year-to-date console sales exceed full-year console s